Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx

International Journal of Cancer

Volumn 86, Issue 3, 2000, Pages 187-193

  Obata, Atsushi ^a   Eura, Masao ^a   Sasaki, Jiichiro ^a   Saya, Hideyuki ^a   Chikamatsu, Kazuaki ^a   Tada, Mitsuhiro ^b   Iggo, Richard D ^c   Yumoto, Eiji ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53; RNA; RNA PRIMERS;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRINKING BEHAVIOR; FEMALE; FRAMESHIFT MUTATION; HUMAN; HUMAN TISSUE; MALE; MISSENSE MUTATION; NONSENSE MUTATION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; BIOASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; OROPHARYNX TUMOR; POLYMERASE CHAIN REACTION; YEAST;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; OROPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; RNA; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

EID: 0034688905     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000320)89:2<187::aid-ijc14>3.0.co;2-v     Document Type: Article

References (29)

1. BLAGOSKLONNY, M.V., Loss of function and p53 protein stabilization. Oncogene, 15, 1889-1893 (1997).
2. BRENNAN, J.A., BOYLE, J.O., KOCH, W.M., GOODMAN, S.N., HRUBAN, R.H., EBY, Y.J., COUCH, M.J., FORASTIERE, A.A. and SIDRANSKY, D., Association between cigarette smoking and mutation of the p53 gene in squamous- cell carcinoma of the head and neck. N. Engl. J. Med., 332, 712-717 (1995).
3. BRUNER, J.M., CONNELLY, J.H. and SAYA, H., p53 protein immunostaining in routinely processed paraffin-embedded sections. Mod. Pathol. 6, 189-194 (1993).
4. CAMINERO, M.J., NÚÑEZ, F., SUÁREZ, C., ABLANEDO, P., RIERA, J.R. and DOMINGUEZ, F., Detection of p53 protein in oropharyngeal carcinoma. Arch. Otolaryngol. Head Neck Surg., 122, 769-772 (1996).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
6. CINCIRIPINI, P.M., HECHT, S.S., HENNINGFIELD, J.E., MANLEY, M.W. and KRAMER, B.S., Tobacco addiction: implications for treatment and cancer prevention. J. nat. Cancer Inst., 89, 1852-1867 (1997).
7. DENISSENKO, M.F., PAO, A., TANG, M.-S. and PFEIFER, G.P., Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432 (1996).
8. ERBER, R., CONRADT, C., HOMANN, N., ENDERS, C., FINCKH, M., DIETZ, A., WEIDAUER, H. and BOSCH, F.X., TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene, 16, 1671-1679 (1998).
9. FIELD, J.K., SPANDIDOS, D.A., MALLIRI, A., GOSNEY, J.R., YIAGNISIS, M. and STELL, P.M., Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Brit. J. Cancer, 64, 573-577 (1991).
10. FIELD, J.K., SPANDIDOS, D.A. and STEEL, P.M., Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking. Lancet, 339, 502-503 (1992).
11. FLAMAN, J.M. and 13 OTHERS, A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. nat. Acad. Sci. (Wash.). 92, 3963-3967 (1995).
12. FRANCESCHI, S., GLOGHINI, A., MAESTRO, R., BARZAN, L., BIDOLI, E., TALAMINI, R., VUKOSAVLJEVIC, T., CARBONE, A. and BOIOCCHI, M., Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract. Int. J. Cancer, 60, 872-876 (1995).
13. FUJIMOTO, H., SASAKI, J.-I., MATSUMOTO, M., SUGA, M., ANDO, Y., IGGO, R., TADA, M., SAYA, H. and ANDO, M., Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn. J. Cancer Res., 89, 696-702 (1998).
14. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
15. HARRIS, C.C. and HOLLSTEIN, M., Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329, 1318-1327 (1993).
16. HARRIS, E.L., Association of oral cancers with alcohol consumption: exploring mechanisms. J. nat. Cancer Inst. 89, 1656-1657 (1997).
17. ISHIOKA, C., FREBOURG, T., YAN, Y.-X., VIDAL, M., FRIEND, S.H., SCHMIDT, S. and IGGO, R., Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature (Genet.), 5, 124-129 (1993).
18. KROPVELD, A., SLOOTWEG, P. J., VAN MANSFELD, A.D.M., BLANKENSTEIN, M.A. and HORDIJK, G.J., Radioresistance and p53 status of T2 laryngeal carcinoma. Cancer, 78, 991-997 (1996).
19. LILOGLOU, T., SCHOLES, A.G.M., SPANDIDOS, D.A., VAUGHAN, E.D., JONES, A.S. and FIELD, J.K., p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res., 57, 4070-4074 (1997).
20. MASIIBERG, A., BOFFETTA, P., WINKELMAN, R. and GARFINKEL, L., Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer, 72, 1369-1375 (1993).
21. MELHEM, M.F., LAW, J.C., EL-ASHMAWY, L., JOHNSON, J.T., LANDRENEAU, R.J., STRIVASTAVA, S. and WHITESIDE, T.L., Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Amer. J. Pathol., 146, 1170-1177 (1995).
22. RAYBAUD-DIOGÈNE, H., FORTIN, A., MORENCY, R., ROY, J., MONTEIL, R.A. and TETSU, B., Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J. clin. Oncol., 15, 1030-1038 (1997).
23. REGUEIRO, C.A., ARAGON, G., MILLÁN, I., VALCARCEL, F.J., DE LA TORRE, A. and MAGALLÓN, R., Prognostic factors for local control, regional control and survival in oropharyngeal squamous cell carcinoma. Europ. J. Cancer, 30A, 2060-2067 (1994).
24. ROWLEY, H., ROLAND, N.J., HELLIWELL, T.R., CASLIN, A., KINSELLA, A.R. and JONES, A.S., p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin. Otolaryngol., 23, 57-62 (1998).
25. SHAHA, A.R., BYERS, R.M. and TERZ, J.J., Oropharyngeal and oral cavity cancer surgical practice guidelines. Oncology, 11, 1211-1216 (1997).
26. SJÖGREN, S., INGANÄS, M., NORBERG, T., INDGREN, A., NORDGREN, H., HOLMBERG, L. and BERGH, J., The p53 gene in brest cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. nat. Cancer Inst., 88, 173-182 (1996).
27. TADA, M., IGGO, R.D., WARIDEL, F., NOZAKI, M., MATSUMOTO, R., SAWAMURA, Y., SHINOHE, Y., IKEDA, J. and ABE, H., Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Mol. Carcinogenesis. 18, 171-176 (1997).
28. WILSON, G.D., RICHMAN, P.I., DISCHE, S., SAUNDERS, M.I., ROBINSON, B., DALEY, F.M. and ROSS, D.A., p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Brit. J. Cancer, 71, 1248-1252 (1995).
29. WYNFORD-THOMAS, D.,P53 in tumour pathology: can we trust immunocytochemistry? J. Pathol., 166, 329-330 (1992).